Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3502616 | 0.78 | — | — | |
| SCHEMBL2404941 | 0.73 | — | — | |
| SCHEMBL6263691 | 0.67 | HSD11B1 (0.30) | — | |
| SCHEMBL14875524 | 0.66 | — | — | |
| SCHEMBL3214699 | 0.64 | — | — | |
| SCHEMBL16964518 | 0.64 | — | — | |
| SCHEMBL1538713 | 0.64 | KMT2A (0.30) | — | |
| SCHEMBL10827154 | 0.62 | — | — | |
| SCHEMBL19183297 | 0.62 | LMNA (0.31) | — | |
| SCHEMBL11757885 | 0.61 | CYP2C19 (0.31) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11072744-B2 | Covalently-bound polybromocyclododecane flame retardants | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-07-27 | — | — | US | disclosed |
| US-20200115633-A1 | COVALENTLY-BOUND POLYBROMOCYCLODODECANE FLAME RETARDANTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11072744-B2 | Covalently-bound polybromocyclododecane flame retardants | PBDC1, PCBP1, SBDS | CYP2C19 1820/4885 |
| US-20200115633-A1 | COVALENTLY-BOUND POLYBROMOCYCLODODECANE FLAME RETARDANTS | PBDC1, PCBP1, SBDS | CYP2C19 1820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.